Related Experiment Video
Updated: Jun 12, 2025

Hypothalamic Kisspeptin Neurons as a Target for Whole-Cell Patch-Clamp Recordings
Published on: March 17, 2023
Kisspeptin in functional hypothalamic amenorrhea: Pathophysiology and therapeutic potential
Aaran H Patel1,2, Kanyada Koysombat1,3, Aureliane Pierret1
1Section of Endocrinology and Investigative Medicine, Imperial College London, London, UK.
Functional hypothalamic amenorrhea (FHA) is a common cause of infertility linked to low energy availability. Kisspeptin neurons regulate reproductive hormones and may offer new treatments for FHA.
Area of Science:
- Reproductive Endocrinology
- Neuroendocrinology
- Metabolic Regulation
Background:
- Functional hypothalamic amenorrhea (FHA) is a prevalent condition causing anovulation, infertility, and low estrogen.
- FHA involves suppressed pulsatile gonadotropin-releasing hormone (GnRH) release, leading to hypogonadotropic hypogonadism.
- It arises from low energy availability (diet, exercise) and stress, potentially influenced by genetic factors.
Purpose of the Study:
- To review the physiological regulation of GnRH pulsatility by kisspeptin.
- To explore how energy status signals modulate kisspeptin neurons and reproductive function.
- To discuss the role of kisspeptin in FHA pathophysiology and its therapeutic potential.
Main Methods:
- Review of physiological regulation of GnRH secretion.
- Analysis of kisspeptin neuron modulation by energy status signals.
- Exploration of endocrine factors in FHA and kisspeptin's role.
Main Results:
- Kisspeptin is a key regulator of the GnRH pulse generator.
- Hypothalamic kisspeptin neurons integrate signals of energy status.
- Kisspeptin neurons are a likely final common pathway for GnRH suppression in FHA.
Conclusions:
- Kisspeptin plays a central role in regulating reproductive function.
- Dysregulation of kisspeptin signaling contributes to FHA.
- Kisspeptin-based therapies hold promise for treating FHA.
Related Concept Videos
Regulation of Food Intake
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
PI3K/mTOR/AKT Signaling Pathway

